SCHEMBL6782252

SCHEMBL6782252

COC(=O)c1cc(I)c(CBr)cc1-c1ccccc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SLC6A3 Q01959 5/20 0.38
SLC6A4 P31645 3/20 0.37
NR4A2 P43354 1/20 0.37
SLC6A2 P23975 1/20 0.37
TSHR P16473 1/20 0.36
MCL1 Q07820 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CFTR P13569 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KMT2A Q03164 1/20 0.35
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
POLQ O75417 1/20 0.34
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6776244 0.88 NR4A2 (0.41) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL6780722 0.84 SLC6A3 (0.42) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL6776274 0.80 MCL1 (0.43) LMNASLC6A3SLC6A4NR4A2SLC6A2
SCHEMBL630123 0.77 SLC6A3 (0.43) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL6772426 0.77 FNTA (0.48) ALDH1A1TSHRHSD17B10KMT2AKDM4E
SCHEMBL628811 0.75 SLC6A3 (0.46) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL6775709 0.72 ALDH1A1 (0.51) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL9549 0.72 SLC6A3 (0.57) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL6625716 0.72 SLC6A3 (0.43) LMNAALDH1A1SLC6A3SLC6A4NR4A2
SCHEMBL22256473 0.71 KDM4E (0.47) ALDH1A1TSHRMAPTHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693123-B2 (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA UNIVERSITY OF PITTSBURGH 2004-02-17 US disclosed
EP-0873123-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2003-04-09 EP disclosed
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 LMNA 1946/4885ALDH1A1 1121/4885SLC6A3 2958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.